Results 81 to 90 of about 23,676 (191)

Efficacy and safety of RET-TKI in advanced RET-rearranged non-small cell lung cancer in China: a real-world retrospective chart review

open access: yesBMC Cancer
Background Selective RET inhibitors have been approved by the Chinese government for the treatment of RET-rearranged non-small cell lung cancer. This study aimed to illustrate the efficacy and safety of selective RET inhibitors in a real-world clinical ...
Siyu Lei   +8 more
doaj   +1 more source

Human biomarker navigator

open access: yesiMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li   +29 more
wiley   +1 more source

The Enteric Nervous System: An Integrative Hub From Development to Systemic Physiology

open access: yesJournal of Experimental Zoology Part A: Ecological and Integrative Physiology, EarlyView.
Unlike a static hardwired circuit, the ENS continuously remodels its transcriptional programs and synaptic connectivity in response to three ecological forces: microbial metabolites, immune cell signals and enteroendocrine cues. ABSTRACT The enteric nervous system (ENS) constitutes the largest and most functionally autonomous subdivision of the ...
Mario Cuchillo‐Hilario   +3 more
wiley   +1 more source

Genetic Mutations in Recurrent/Metastatic Papillary Thyroid Carcinoma

open access: yesThe Laryngoscope, EarlyView.
We investigated the mutational landscape and prognostic implications of recurrent/metastatic papillary thyroid carcinoma using nationwide C‐CAT data from 348 patients. CDKN2A, KMT2D, and concurrent TERT/BRAF mutations were independently associated with poorer overall survival, highlighting the potential prognostic value of comprehensive genomic ...
Hiromi Nagano   +3 more
wiley   +1 more source

Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectives

open access: yesCell Communication and Signaling
Medullary thyroid carcinoma (MTC) is a rare type of thyroid malignancy that accounts for approximately 1–2% of all thyroid cancers (TCs). MTC include hereditary and sporadic cases, the former derived from a germline mutation of rearrangement during ...
Ying Zhang   +8 more
doaj   +1 more source

RET Inhibitors in Non-Small-Cell Lung Cancer. [PDF]

open access: yesCancers (Basel), 2021
Cascetta P   +17 more
europepmc   +1 more source

Network based approach identifies miR‐145‐3p as a central regulatory hub associated to the progression from localized to metastatic medullary thyroid carcinoma

open access: yesThe Journal of Pathology, EarlyView.
Abstract Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor originating from calcitonin producing C‐cells and accounts for 1–5% of thyroid cancers. Total thyroidectomy is curative in localized disease (N0), whereas lymph node metastases (N1) are associated with poorer prognosis.
Anna Citarella   +24 more
wiley   +1 more source

Within‐tree spatial heterogeneity of sap flow velocities and wood properties and its effect on the uncertainty of tree level sap flux estimates

open access: yesPLANTS, PEOPLE, PLANET, EarlyView.
As forests are important for biodiversity and recreation and provide vital resources globally, it is essential that their health can be accurately monitored, for example, by using sap flow probes to measure tree water uptake. We investigated whether sap flow measurements might differ at various locations within the same tree due to variation in wood ...
Stefan Seeger   +2 more
wiley   +1 more source

Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC and improve survival outcomes. [PDF]

open access: yesJ Cancer Res Clin Oncol, 2023
Lu C   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy